We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$607M
AUM Growth
-$13.7M
Cap. Flow
-$17.5M
Cap. Flow %
-2.88%
Top 10 Hldgs %
21.7%
Holding
410
New
79
Increased
109
Reduced
121
Closed
71

Top Sells

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$8.31M
2
META icon
Meta Platforms (Facebook)
META
+$7.78M
3
GPRO icon
GoPro
GPRO
+$7.18M
4
LLY icon
Eli Lilly
LLY
+$7.05M
5
AGN
Allergan plc
AGN
+$5.59M

Sector Composition

Rank Sector Weight
1 Technology 26.07%
2 Healthcare 14.08%
3 Industrials 10.62%
4 Energy 10.51%
5 Consumer Discretionary 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
351
Edwards Lifesciences
EW
$53.6B
-25,395
Closed -$1.02M
F icon
352
Ford
F
$55.1B
-10,437
Closed -$126K
FCX icon
353
Freeport-McMoran
FCX
$96.9B
-10,229
Closed -$111K
GEN icon
354
Gen Digital
GEN
$17.1B
-12,403
Closed -$311K
GPRO icon
355
GoPro
GPRO
$106M
-430,597
Closed -$7.18M
HAIN icon
356
Hain Celestial
HAIN
$52.9M
-19,233
Closed -$684K
HP icon
357
Helmerich & Payne
HP
$4.29B
-3,181
Closed -$214K
HUBS icon
358
HubSpot
HUBS
$10.5B
-19,602
Closed -$1.13M
INFU icon
359
InfuSystem Holdings
INFU
$244M
-87,686
Closed -$244K
ISRG icon
360
Intuitive Surgical
ISRG
$142B
-6,588
Closed -$531K
JNJ icon
361
Johnson & Johnson
JNJ
$629B
-17,788
Closed -$2.1M
NBIX icon
362
Neurocrine Biosciences
NBIX
$15.9B
-35,361
Closed -$1.79M
PRDO icon
363
Perdoceo Education
PRDO
$1.96B
-134,022
Closed -$910K
PRLB icon
364
Protolabs
PRLB
$2.17B
-6,417
Closed -$384K
PYPL icon
365
PayPal
PYPL
$50.6B
-6,610
Closed -$271K
QCOM icon
366
Qualcomm
QCOM
$171B
-4,236
Closed -$290K
SGRY icon
367
Surgery Partners
SGRY
$2.01B
-43,864
Closed -$888K
SLV icon
368
iShares Silver Trust
SLV
$31.8B
-31,642
Closed -$576K
SPGI icon
369
S&P Global
SPGI
$121B
-65,687
Closed -$8.31M
TER icon
370
Teradyne
TER
$63B
-12,652
Closed -$273K
TMO icon
371
Thermo Fisher Scientific
TMO
$223B
-5,745
Closed -$914K
TNDM icon
372
Tandem Diabetes Care
TNDM
$1.63B
-5,745
Closed -$440K
TRIB
373
Trinity Biotech
TRIB
$7.86M
-280
Closed -$554K
VMC icon
374
Vulcan Materials
VMC
$36.3B
-24,733
Closed -$2.81M
VRNT
375
DELISTED
Verint Systems
VRNT
-19,748
Closed -$379K

Similar funds

Essex Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Essex Investment Management held 410 positions worth $607M, down 2.2% from $621M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Essex Investment Management's Q4 2016 filing shows 79 new, 109 increased, 121 reduced and 71 closed positions. Its largest new stake was APA Corp: 89,478 shares worth $5.68M. The largest sale was S&P Global, an estimated $8.31M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Essex Investment Management's largest Q4 2016 buy was APA Corp: 89,478 shares worth $5.68M.
  • Essex Investment Management added most to Southwestern Energy Company in Q4 2016, an estimated $6.22M increase.
  • Essex Investment Management's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $7.78M.
  • Essex Investment Management fully exited S&P Global in Q4 2016, selling an estimated $8.31M.
  • Essex Investment Management's ten largest holdings make up 22% of its $607M portfolio in Q4 2016.
  • Essex Investment Management opened 79 new positions and closed 71 in Q4 2016.
  • Essex Investment Management's portfolio value fell 2.2% quarter-over-quarter to $607M.

Based on Essex Investment Management's 13F filing for Q4 2016, filed 8 Feb 2017.